A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): a study protocol

Yining Yang, Li Li, Yongzhe Zheng, Qingfeng Liu, Xianfeng Wei, Xinyuan Gong, Wei Wang, Peng Lin, Yining Yang, Li Li, Yongzhe Zheng, Qingfeng Liu, Xianfeng Wei, Xinyuan Gong, Wei Wang, Peng Lin

Abstract

Background: Laryngocarcinoma (LC), in most cases a squamous cell carcinoma, accounts for 1 ~ 5% of the incidence of all tumors. At present, laryngocarcinoma is mainly managed with the integration of surgery and radio- and chemo-therapies. The current development trend of treatment is to improve the local control rate of tumor and the quality of life of patients. Intraoperative radiation therapy (IORT) is a radiotherapy that delivers single high dose irradiation at a close range to the tumor bed during the surgical operation process. It has particular radiobiological advantages in protecting normal surrounding tissues by directly applying the irradiation dose to the high-risk tumor bed area. Two forms of IORT, i.e., high dose rate (HDR) brachytherapy and external beam radiotherapy (EBRT, including electron and photono IORT), had been studied before the treatment of head and neck tumors (including laryngocarcinoma). However, no relevant assessment had been carried out on 50KV low-energy X-ray. We are convinced by certain arguments that the application of low-energy X-ray for intraoperative local radiotherapy of laryngocarcinoma can not only achieve the therapeutic effect of IORT but also reduce the incidence of high-energy irradiation related toxic and side effects. The purpose of this study is to observe the safety and short-term efficacy of IORT when used in conjunction with standard of care for the treatment of local advanced laryngocarcinoma (LAL).

Methods/design: In consideration of the applications of precise targeted IORT in oncosurgery and in line with the application range and reference clinical medical guidances approved by SFDA (ZEISS radiosurgical operation system has been used for the treatment of solid tumors since 31 December, 2013 with an approval from SFDA), we have preliminarily planned the tumors suitable for IORT, determined the members of MDT in our hospital, improved the MDT diagnosis and treatment processes for the tumors, established the standards, indications and contraindications for the application of IORT, determined the indicators to be observed after the treatment of tumors with surgical operations plus IORT, and carried out follow-up visits and statistical analysis. This is a single-arm, prospective Phase II clinical trial of the treatment of LAL patients with IORT + EBRT. The study subjects are followed up for statistics and information of their acute/chronic toxic reactions and local control rate, DFS, and OS etc. The safety and short-term efficacy of the application of IORT as SIB for the treatment of LAL. The sample size of the study is 125 subjects.

Discussion: The safety and efficacy of IORT for the treatment of head and neck cancers have been proven in studies by multiple institutions (1-3). The purpose of this study is to investigate the maximum safe dose and short-term efficacy of IORT for providing a theoretical basis for clinical trials.

Trial registration: Trial registration: Clinicaltrials.gov , NCT04278638. Registered 18 February 2020 - prospectively registered, https://ichgcp.net/clinical-trials-registry/NCT04278638.

Keywords: IORT; Local advanced laryngocarcinoma; Local control; Low-energy X-ray.

Conflict of interest statement

No competing interests.

Figures

Fig. 1
Fig. 1
Intraoperative interstitial irradiation dosiology
Fig. 2
Fig. 2
The Intrabeam IORT procedure
Fig. 3
Fig. 3
Treatment schedule

References

    1. Freddie B, Jacques F, Isabelle S, et al. Global Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians; 2011.
    1. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers Version 1. 2019 - March 6, 2019.
    1. Yiting J. A meta-analysis on selection of strategies for treatment of local advanced laryngocarcinoma. PhD thesis. Chongqing Medical University, Otolaryngology Department; 2016.
    1. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–8.
    1. Rosenthal DI, Liu L, Lee JH, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24(2):115–26.
    1. Kyrgias G, Hajiioannou J, Tolia M, Kouloulias V, Lachanas V, Skoulakis C, Skarlatos I, Rapidis A, Bizakis I. Intraoperative radiation therapy (IORT) in headand neck cancer systematic review and meta-analysis. Medicine. 2016;95(50):e5035. doi: 10.1097/MD.0000000000005035.
    1. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Jr, Bevan A, Pouliot J, Konski AA, Wallner PE. Electronic Brachytherapy Working G. American Society for Therapeutic Radiology and Oncology (ASTRO) emerging technology committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):963–972. doi: 10.1016/j.ijrobp.2009.10.068.
    1. Liu Q, Schneider F, Ma L, Wenz F, Herskind C. Relative biologic effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation. Int J Radiat Oncol Biol Phys. 2013;85(4):1127–1133. doi: 10.1016/j.ijrobp.2012.08.005.
    1. Abe M, Shibamoto Y, Ono K, et al. Intraoperative radiation therapy for carcinoma of the stomach and pancreas. Front Radiat Ther Oncol. 1991;25:258–269. doi: 10.1159/000429597.
    1. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys. 1981;7:863–868. doi: 10.1016/0360-3016(81)90001-8.
    1. Freeman SB, Hamaker RC, Singer MI, Pugh N, Garrett P, Ross D. Intraoperative radiotherapy of head and neck cancer. Arch Otolaryngol Head Neck Surg. 1990;116:165–168. doi: 10.1001/archotol.1990.01870020041011.
    1. Lara H, Al Feghali Karine A, Paul R, et al. Intraoperative radiation therapy: a promising treatment modality in head and neck cancer. Front Oncol. 2017;7:148.
    1. Toita T, Nakano M, Takizawa Y, Sueyama H, Kakihana Y, Kushi A, et al. Intraoperative radiation therapy (IORT) for head and neck cancer. Int J Radiat Oncol Biol Phys. 1994;30:1219–1224. doi: 10.1016/0360-3016(94)90332-8.
    1. Teckie S, Scala LM, Ho F, Wolden S, Chiu J, Cohen GN, et al. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy. 2013;12:228–234. doi: 10.1016/j.brachy.2013.01.165.
    1. Zeidan YH, Yeh A, Weed D, Terry C, Freeman S, Krowiak E, et al. Intraoperative radiation therapy for advanced cervical metastasis: a single institution experience. Radiat Oncol. 2011;6:72. doi: 10.1186/1748-717X-6-72.
    1. Pinheiro AD, Foote RL, McCaffrey TV, Kasperbauer JL, Bonner JA, Olsen KD, et al. Intraoperative radiotherapy for head and neck and skull base cancer. Head Neck. 2003;25:217–225. doi: 10.1002/hed.10203.
    1. Freeman SB, Hamaker RC, Rate WR, Garrett PG, Pugh N, Huntley TC, et al. Management of advanced cervical metastasis using intraoperative radiotherapy. Laryngoscope. 1995;105:575–578. doi: 10.1288/00005537-199506000-00003.
    1. Chen AM, Bucci MK, Singer MI, Garcia J, Kaplan MJ, Chan AS, et al. Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience. Int J Radiat Oncol Biol Phys. 2007;67:122–129. doi: 10.1016/j.ijrobp.2006.08.038.
    1. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–578. doi: 10.1016/S0360-3016(01)01690-X.
    1. Schleicher UM, Phonias C, Spaeth J, Schlöndorff G, Ammon J, Andreopoulos D. Intraoperative radiotherapy for pre-irradiated head and neck cancer. Radiother Oncol. 2001;58(1):77–81. doi: 10.1016/S0167-8140(00)00297-8.
    1. Perry DJ, Chan K, Wolden S, Zelefsky MJ, Chiu J, Cohen G, et al. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;76(4):1140–1146. doi: 10.1016/j.ijrobp.2009.03.025.
    1. Chen AM, Garcia J, Bucci MK, Chan AS, Kaplan MJ, Singer MI, et al. Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy. Head Neck. 2008;30(1):2–9. doi: 10.1002/hed.20651.
    1. APA Kyrgias G, Hajiioannou J, Tolia M, Kouloulias V, Lachanas V, Skoulakis C, Skarlatos I, Rapidis A, Bizakis I. Intraoperative radiation therapy (IORT) in head and neck cancer. Medicine. 2016;95(50):e5035. doi: 10.1097/MD.0000000000005035.
    1. Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24:115–126. doi: 10.1002/hed.10038.
    1. Haller JR, Mountain RE, Schuller DE, Nag S. Mortality and morbidity with intraoperative radiotherapy for head and neck cancer. Am J Otolaryngol. 1996;17:308–310. doi: 10.1016/S0196-0709(96)90016-2.
    1. ​Sethi A, Emami B, Small W Jr, Thomas TO. Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations. Front Oncol. 2018;8:74.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe